bibliographic entry 12595394 [be/12595394]
https://w3id.org/oc/corpus/be/12595394

is a
content
  • Venook, A, N, D, Hollis, D, Sutherland, S, Goldberg, R, Alberts, S, Benson, A, Wade, J, Schilsky, R, Mayer, R. Phase III study of irinotecan/5FU/LV (FOLFIRI) or oxaliplatin/5FU/LV (FOLFOX) ± cetuximab for patients (pts) with untreated metastatic adenocarcinoma of the colon or rectum (MCRC): CALGB 80203 preliminary results, Paper presented at: ASCO Annual Meeting, 2006
references